ADC Therapeutics raises $86.6M via private placement
- $86.6 million private placement closing Oct 22, 2026
- Pre-funded warrants to purchase 48.1M shares at $1.32 each
- Loan agreement amended to reduce principal to $50M
ADCT
ADC Therapeutics SA SEC filings
Every EDGAR filing for ADC Therapeutics SA (ADCT), newest first, with AI summaries and stories.
- Ticker
- ADCT
- CIK
- 1771910
- Sector
- Biotech and pharma
- Latest filing
- 6d
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Filings
8-KADC Therapeutics SAADCTLIVE SCHEDULE 13GADC Therapeutics SAADCTLIVE Ownership stake disclosure by Nantahala Capital Management, LLC
Nantahala Capital Management, LLC, filed by
S-8ADC Therapeutics SAADCTLIVE 10-QADC Therapeutics SAADCTLIVE 8-KADC Therapeutics SAADCTLIVE SCHEDULE 13GADC Therapeutics SAADCTLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
4ADC Therapeutics SAADCTLIVE 4 insider filings
Mohamed Zaki, insider filing for ADCT
Show all 4
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
Mohamed Zaki, reporting
8-KADC Therapeutics SAADCTLIVE 8-KADC Therapeutics SAADCTLIVE 4ADC Therapeutics SAADCTLIVE 7 insider filings
Robert Azelby, insider filing for ADCT
Show all 7
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
Robert Azelby, reporting
8-KADC Therapeutics SAADCTLIVE 8-KADC Therapeutics SAADCTLIVE 10-QADC Therapeutics SAADCTLIVE 8-KADC Therapeutics SAADCTLIVE SCHEDULE 13G/AADC Therapeutics SAADCTLIVE Ownership stake disclosure by Redmile Group, LLC (amended)
Redmile Group, LLC, filed by
DEFA14AADC Therapeutics SAADCTLIVE DEF 14AADC Therapeutics SAADCTLIVE 424B3ADC Therapeutics SAADCTLIVE PRE 14AADC Therapeutics SAADCTLIVE SCHEDULE 13G/AADC Therapeutics SAADCTLIVE Ownership stake disclosure by Redmile Group, LLC (amended)
Redmile Group, LLC, filed by
4ADC Therapeutics SAADCTLIVE Redmile Group, LLC, insider filing for ADCT
Redmile Group, LLC, reporting · Jeremy Green, reporting · +1 more
EFFECTADC Therapeutics SAADCTLIVE 424B3ADC Therapeutics SAADCTLIVE 10-KADC Therapeutics SAADCTLIVE S-3ADC Therapeutics SAADCTLIVE ARSADC Therapeutics SAADCTLIVE 8-KADC Therapeutics SAADCTLIVE 8-KADC Therapeutics SAADCTLIVE 4ADC Therapeutics SAADCTLIVE 5 insider filings
Lisa Michelle Kallebo, insider filing for ADCT
Show all 5
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
- 4Insider filing for ADCT
Lisa Michelle Kallebo, reporting
SCHEDULE 13G/AADC Therapeutics SAADCTLIVE Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
SCHEDULE 13G/AADC Therapeutics SAADCTLIVE 3 13G filings
Ownership stake disclosure by Point72 Asset Management, L.P. (amended)
Show all 3
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Point72 Asset Management, L.P., filed by
SCHEDULE 13G/AADC Therapeutics SAADCTLIVE Ownership stake disclosure by Prosight Management, LP (amended)
Prosight Management, LP, filed by
8-KADC Therapeutics SAADCTLIVE 8-KADC Therapeutics SAADCTLIVE EFFECTADC Therapeutics SAADCTLIVE